Neuroone Medical Technologies (NMTC) Free Cash Flow (2010 - 2026)

Neuroone Medical Technologies (NMTC) has reported Free Cash Flow for 17 consecutive years, with -$1.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow rose 26.91% year-over-year to -$1.1 million; the trailing twelve-month figure through Jun 2026 stood at -$7.2 million (down 75.25% YoY), and the FY2025 full-year result was -$2.9 million, up 73.78% from the prior year.
• Free Cash Flow rose to -$1.1 million in Q2 2026 per NMTC's latest filing, from -$1.4 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $951635.0 in Q3 2022 and bottomed at -$3.8 million in Q4 2023.
• Historically, Free Cash Flow has averaged -$2.1 million across 5 years, with a median of -$2.5 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Free Cash Flow jumped 146.1% in 2022, then sank 2205.03% in 2026.
• Over 5 years, Free Cash Flow stood at -$3.5 million in 2022, then fell by 9.78% to -$3.8 million in 2023, then surged by 104.77% to $183633.0 in 2024, then plunged by 1818.97% to -$3.2 million in 2025, then soared by 65.11% to -$1.1 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$1.1 million, -$1.4 million, and -$3.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.